Management of perianal fistulas in Cohn's disease: An up-to-date review

World Journal of Gastroenterology

Volumn 21, Issue 5, 2015, Pages 1394-1403

  Marzo, Manuela ^a   Felice, Carla ^a   Pugliese, Daniela ^a   Andrisani, Gianluca ^a   Mocci, Giammarco ^a   Armuzzi, Alessandro ^a   Guidi, Luisa ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Crohn's disease; Drug therapy; Perianal fistula; Surgery; Tumor necrosis factor alpha

Indexed keywords

ANTIBIOTIC AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSCESS DRAINAGE; ANUS FISTULA; ARTICLE; CROHN DISEASE; CURETTAGE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; EXTRACELLULAR MATRIX; FISTULOGRAPHY; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; LIGATION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW (TOPIC); COMPLICATION; DIAGNOSTIC IMAGING; MULTIMODALITY CANCER THERAPY; PREDICTIVE VALUE; PROCEDURES; RECTAL FISTULA; RISK FACTOR; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; CROHN DISEASE; DIAGNOSTIC IMAGING; HUMANS; PREDICTIVE VALUE OF TESTS; RECTAL FISTULA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84922569365     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i5.1394     Document Type: Article

References (88)

1. Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21: 525-527 [PMID: 7429313 DOI: 10.1136/gut.21.6.525]
2. Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880 [PMID: 11910338 DOI: 10.1053/gast.2002.32362]
3. Ingle SB, Loftus EV. The natural history of perianal Crohn's disease. Dig Liver Dis 2007; 39: 963-969 [PMID: 17720635 DOI: 10.1016/j.dld.2007.07.154]
4. Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101 [PMID: 21122490 DOI: 10.1016/j.crohns.2009.09.009]
5. Dignass AU. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 2001; 7: 68-77 [PMID: 11233665 DOI: 10.1097/00054725-200102000-00014]
6. Frei SM, Hemsley C, Pesch T, Lang S, Weber A, Jehle E, Rühl A, Fried M, Rogler G, Scharl M. The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae. PLoS One 2013; 8: e78882 [PMID: 24250816 DOI: 10.1371/journal.pone.0078882]
7. Scharl M, Rogler G. Pathophysiology of fistula formation in Crohn's disease. World J Gastrointest Pathophysiol 2014; 5: 205-212 [PMID: 25133023 DOI: 10.4291/wjgp.v5.i3.205]
8. Radlmayr M, Török HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122: 2091-2092 [PMID: 12055616 DOI: 10.1053/gast.2002.34020]
9. Bataille F, Klebl F, Rümmele P, Schroeder J, Farkas S, Wild PJ, Fürst A, Hofstädter F, Schölmerich J, Herfarth H, Rogler G. Morphological characterisation of Crohn's disease fistulae. Gut 2004; 53: 1314-1321 [PMID: 15306592 DOI: 10.1136/gut.2003.038208]
10. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976; 63: 1-12 [PMID: 1267867 DOI: 10.1002/bjs.1800630102]
11. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125: 1508-1530 [PMID: 14598268 DOI: 10.1016/j.gastro.2003.08.025]
12. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20: 27-32 [PMID: 7884173 DOI: 10.1097/00004836-199501000-00008]
13. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405 [PMID: 10228190 DOI: 10.1056/NEJM199905063401804]
14. Villa C, Pompili G, Franceschelli G, Munari A, Radaelli G, Maconi G, Cornalba GP. Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn's disease. Eur J Radiol 2012; 81: 616-622 [PMID: 21316171 DOI: 10.1016/j.ejrad.2011.01.046]
15. Horsthuis K, Ziech ML, Bipat S, Spijkerboer AM, de Bruine-Dobben AC, Hommes DW, Stoker J. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease. Clin Imaging 2011; 35: 360-365 [PMID: 21872125 DOI: 10.1016/j.clinimag.2010.09.003]
16. Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98: 332-339 [PMID: 12591051 DOI: 10.1016/S0002-9270(02)05909-9]
17. Losco A, Viganò C, Conte D, Cesana BM, Basilisco G. Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound. Inflamm Bowel Dis 2009; 15: 742-749 [PMID: 19023861 DOI: 10.1002/ibd.20826]
18. Regueiro M. The role of endoscopy in the evaluation of fistulizing Crohn's disease. Gastrointest Endosc Clin N Am 2002; 12: 621-633 [PMID: 12486948 DOI: 10.1016/S1052-5157(02)00013-2]
19. Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, Zinsmeister AR, Norton ID, Boardman LA, Devine RM, Wolff BG, Young-Fadok TM, Diehl NN, Pemberton JH, Sandborn WJ. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121: 1064-1072 [PMID: 11677197 DOI: 10.1053/gast.2001.28676]
20. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003; 9: 98-103 [PMID: 12769443 DOI: 10.1097/00054725-200303000-00003]
21. Law PJ, Bartram CI. Anal endosonography: technique and normal anatomy. Gastrointest Radiol 1989; 14: 349-353 [PMID: 2680741 DOI: 10.1007/BF01889235]
22. West RL, Dwarkasing S, Felt-Bersma RJ, Schouten WR, Hop WC, Hussain SM, Kuipers EJ. Hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging in evaluating perianal fistulas: agreement and patient preference. Eur J Gastroenterol Hepatol 2004; 16: 1319-1324 [PMID: 15618839 DOI: 10.1097/00042737-200412000 -00014]
23. Navarro-Luna A, García-Domingo MI, Rius-Macías J, Marco-Molina C. Ultrasound study of anal fistulas with hydrogen peroxide enhancement. Dis Colon Rectum 2004; 47: 108-114 [PMID: 14719157 DOI: 10.1007/s10350-003-0015-8]
24. Cheong DM, Nogueras JJ, Wexner SD, Jagelman DG. Anal endosonography for recurrent anal fistulas: image enhancement with hydrogen peroxide. Dis Colon Rectum 1993; 36: 1158-1160 [PMID: 8253014 DOI: 10.1007/BF02052266]
25. Zawadzki A, Starck M, Bohe M, Thorlacius H. A unique 3D endoanal ultrasound feature of perianal Crohn's fistula: the 'Crohn ultrasound fistula sign'. Colorectal Dis 2012; 14: e608-e611 [PMID: 22507755 DOI: 10.1111/j.1463-1318.2012.03047.x]
26. Siddiqui MR, Ashrafian H, Tozer P, Daulatzai N, Burling D, Hart A, Athanasiou T, Phillips RK. A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 2012; 55: 576-585 [PMID: 22513437 DOI: 10.1097/DCR.0b013e318249d26c]
27. Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut 1995; 36: 407-410 [PMID: 7698701 DOI: 10.1136/gut.36.3.407]
28. Halligan S, Stoker J. Imaging of fistula in ano. Radiology 2006; 239: 18-33 [PMID: 16567481 DOI: 10.1148/radiol.2391041043]
29. Hori M, Oto A, Orrin S, Suzuki K, Baron RL. Diffusion-weighted MRI: a new tool for the diagnosis of fistula in ano. J Magn Reson Imaging 2009; 30: 1021-1026 [PMID: 19856434 DOI: 10.1002/jmri.21934]
30. Buchanan GN, Halligan S, Bartram CI, Williams AB, Tarroni D, Cohen CR. Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology 2004; 233: 674-681 [PMID: 15498901 DOI: 10.1148/radiol.2333031724]
31. Sahni VA, Ahmad R, Burling D. Which method is best for imaging of perianal fistula? Abdom Imaging 2008; 33: 26-30 [PMID: 17805919 DOI: 10.1007/s00261-007-9309-y]
32. Campari A, Giovanni M, Tonolini M, Cassinotti A, Ardizzone S, De Franchis R, Bianco R. Accuracy of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) in the assessment of perianal Crohn's Disease (CD). Dig Liver Dis 2011; 43: S134-S5 [DOI: 10.1016/S1590-8658(11)60192-8]
33. Maconi G, Tonolini M, Monteleone M, Bezzio C, Furfaro F, Villa C, Campari A, Dell Era A, Sampietro G, Ardizzone S, de Franchis R. Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn's disease. Inflamm Bowel Dis 2013; 19: 2737-2743 [PMID: 24193154 DOI: 10.1097/01.MIB.0000436274.95722.e5]
34. Gecse KB, Bemelman W, Kamm MA, Stoker J, Khanna R, Ng SC, Panés J, van Assche G, Liu Z, Hart A, Levesque BG, D' Haens G. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut 2014; 63: 1381-1392 [PMID: 24951257 DOI: 10.1136/gutjnl-2013-306709]
35. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83: 383-387 [PMID: 7084615]
36. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79: 533-540 [PMID: 6741906]
37. Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15: 17-24 [PMID: 18668682 DOI: 10.1002/ibd.20608]
38. Maeda Y, Ng SC, Durdey P, Burt C, Torkington J, Rao PK, Mayberry J, Moshkovska T, Stone CD, Carapeti E, Vaizey CJ. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg 2010; 97: 1340-1347 [PMID: 20632322 DOI: 10.1002/bjs.7121]
39. Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1113-1120 [PMID: 14653831 DOI: 10.1046/j.1365-2036.2003.01793.x]
40. West RL, van der Woude CJ, Hansen BE, Felt-Bersma RJ, van Tilburg AJ, Drapers JA, Kuipers EJ. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20: 1329-1336 [PMID: 15606395 DOI: 10.1111/j.1365-2036.2004.02247.x]
41. Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van Bodegraven AA, van der Woude CJ. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 2014; 63: 292-299 [PMID: 23525574 DOI: 10.1136/gutjnl-2013-304488]
42. Chande N, Tsoulis DJ, MacDonald JK. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2013; 4: CD000545 [PMID: 23633304 DOI: 10.1002/14651858.CD000545.pub4]
43. Egan LJ, Sandborn WJ, Tremaine WJ. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 1998; 93: 442-448 [PMID: 9517654 DOI: 10.1111/j.1572-0241.1998.00442.x]
44. Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 1993; 88: 646-649 [PMID: 8480725]
45. Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125: 380-388 [PMID: 12891539 DOI: 10.1016/S0016-5085(03)00877-1]
46. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 2003; 18: 1003-1008 [PMID: 14616166 DOI: 10.1046/j.1365-2036.2003.01790.x]
47. Plamondon S, Ng SC, Kamm MA. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies. Aliment Pharmacol Ther 2007; 25: 557-567 [PMID: 17305756 DOI: 10.1111/j.1365-2036.2006.03239.x]
48. Oikonomopoulos A, van Deen WK, Hommes DW. Anti-TNF antibodies in inflammatory bowel disease: do we finally know how it works? Curr Drug Targets 2013; 14: 1421-1432 [PMID: 23627866 DOI: 10.2174/13894501113149990164]
49. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 644-659, quiz 660 [PMID: 21407183 DOI: 10.1038/ajg.2011.73]
50. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876-885 [PMID: 14985485 DOI: 10.1056/NEJMoa030815]
51. Sands BE, Blank MA, Diamond RH, Barrett JP, Van Deventer SJ. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther 2006; 23: 1127-1136 [PMID: 16611273 DOI: 10.1111/j.1365-2036.2006.02878.x]
52. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005; 128: 862-869 [PMID: 15825070 DOI: 10.1053/j.gastro.2005.01.048]
53. Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11: 975-981.e1-4 [PMID: 23376316 DOI: 10.1016/j.cgh.2012.12.042]
54. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395 [PMID: 20393175 DOI: 10.1056/NEJMoa0904492]
55. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007; 132: 52-65 [PMID: 17241859 DOI: 10.1053/j.gastro.2006.11.041]
56. Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 58: 940-948 [PMID: 19201775 DOI: 10.1136/gut.2008.159251]
57. Lichtiger S, Binion DG, Wolf DC, Present DH, Bensimon AG, Wu E, Yu AP, Cardoso AT, Chao J, Mulani PM, Lomax KG, Kent JD. The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment Pharmacol Ther 2010; 32: 1228-1239 [PMID: 20955442 DOI: 10.1111/j.1365-2036.2010.04466.x]
58. Echarri A, Castro J, Barreiro M, Carpio D, Pereira S, Lorenzo A. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure. J Crohns Colitis 2010; 4: 654-660 [PMID: 21122576 DOI: 10.1016/j.crohns.2010.07.012]
59. Schreiber S, Lawrance IC, Thomsen OØ, Hanauer SB, Bloomfield R, Sandborn WJ. Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 185-193 [PMID: 21083671 DOI: 10.1111/j.1365-2036.2010.04509.x]
60. Orlando A, Armuzzi A, Papi C, Annese V, Ardizzone S, Biancone L, Bortoli A, Castiglione F, D'Incà R, Gionchetti P, Kohn A, Poggioli G, Rizzello F, Vecchi M, Cottone M. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis 2011; 43: 1-20 [PMID: 20843756 DOI: 10.1016/j.dld.2010.07.010]
61. White RA, Eisenstat TE, Rubin RJ, Salvati EP. Seton management of complex anorectal fistulas in patients with Crohn's disease. Dis Colon Rectum 1990; 33: 587-589 [PMID: 1694476 DOI: 10.1007/BF02052212]
62. Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg 2004; 91: 476-480 [PMID: 15048751 DOI: 10.1002/bjs.4466]
63. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-1841 [PMID: 17041753 DOI: 10.1007/s10350-006-0656-5]
64. Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50: 1754-1760 [PMID: 17899271 DOI: 10.1007/s10350-007-9077-3]
65. Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003; 46: 577-583 [PMID: 12792431 DOI: 10.1007/s10350-004-6611-4]
66. Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D. Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis 2005; 7: 164-168 [PMID: 15720356 DOI: 10.1111/j.1463-1318.2004.00749.x]
67. Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R, Yamashita Y, Maeda K, Aoyagi K. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Hepatogastroenterology 2010; 57: 3-7 [PMID: 20422862]
68. Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano. Dis Colon Rectum 2010; 53: 486-495 [PMID: 20305451 DOI: 10.1007/DCR.0b013e3181ce8b01]
69. Grimaud JC, Munoz-Bongrand N, Siproudhis L, Abramowitz L, Sénéjoux A, Vitton V, Gambiez L, Flourié B, Hébuterne X, Louis E, Coffin B, De Parades V, Savoye G, Soulé JC, Bouhnik Y, Colombel JF, Contou JF, François Y, Mary JY, Lémann M. Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology 2010; 138: 2275-2281, 2281.e1 [PMID: 20178792 DOI: 10.1053/j.gastro.2010.02.013]
70. Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum 2002; 45: 1608-1615 [PMID: 12473883 DOI: 10.1007/s10350-004-7247-0]
71. Vitton V, Gasmi M, Barthet M, Desjeux A, Orsoni P, Grimaud JC. Long-term healing of Crohn's anal fistulas with fibrin glue injection. Aliment Pharmacol Ther 2005; 21: 1453-1457 [PMID: 15948812 DOI: 10.1111/j.1365-2036.2005.02456.x]
72. Loungnarath R, Dietz DW, Mutch MG, Birnbaum EH, Kodner IJ, Fleshman JW. Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum 2004; 47: 432-436 [PMID: 14978618 DOI: 10.1007/s10350-003-0076-8]
73. Johnson EK, Gaw JU, Armstrong DN. Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulas. Dis Colon Rectum 2006; 49: 371-376 [PMID: 16421664 DOI: 10.1007/s10350-005-0288-1]
74. O'Connor L, Champagne BJ, Ferguson MA, Orangio GR, Schertzer ME, Armstrong DN. Efficacy of anal fistula plug in closure of Crohn's anorectal fistulas. Dis Colon Rectum 2006; 49: 1569-1573 [PMID: 16998638 DOI: 10.1007/s10350-006-0695-y]
75. O'Riordan JM, Datta I, Johnston C, Baxter NN. A systematic review of the anal fistula plug for patients with Crohn's and non-Crohn's related fistula-in-ano. Dis Colon Rectum 2012; 55: 351-358 [PMID: 22469804 DOI: 10.1097/DCR.0b013e318239d1e4]
76. Rojanasakul A. LIFT procedure: a simplified technique for fistula-in-ano. Tech Coloproctol 2009; 13: 237-240 [PMID: 19636496 DOI: 10.1007/s10151-009-0522-2]
77. Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease. Ann Surg 2014; 260: 1057-1061 [PMID: 24374520]
78. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48: 1416-1423 [PMID: 15933795 DOI: 10.1007/s10350-005-0052-6]
79. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52: 79-86 [PMID: 19273960 DOI: 10.1007/DCR.0b013e3181973487]
80. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 2011; 60: 788-798 [PMID: 21257987 DOI: 10.1136/gut.2010.214841]
81. de la Portilla F, Alba F, García-Olmo D, Herrerías JM, González FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn' s disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 2013; 28: 313-323 [PMID: 23053677 DOI: 10.1007/s00384-012-1581-9]
82. Poggioli G, Laureti S, Pierangeli F, Rizzello F, Ugolini F, Gionchetti P, Campieri M. Local injection of Infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum 2005; 48: 768-774 [PMID: 15768185 DOI: 10.1007/s10350-004-0832-4]
83. Poggioli G, Laureti S, Pierangeli F, Bazzi P, Coscia M, Gentilini L, Gionchetti P, Rizzello F. Local injection of adalimumab for perianal Crohn's disease: better than infliximab? Inflamm Bowel Dis 2010; 16: 1631 [PMID: 20848458 DOI: 10.1002/ibd.21210]
84. Tonelli F, Giudici F, Asteria CR. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Dis Colon Rectum 2012; 55: 870-875 [PMID: 22810472 DOI: 10.1097/DCR.0b013e31825af532]
85. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 2006; 41: 1064-1072 [PMID: 16938720 DOI: 10.1080/00365520600609941]
86. Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003; 17: 1145-1151 [PMID: 12752351 DOI: 10.1046/j.1365-2036.2003.01561.x]
87. Deroide G, Deroide JP. [Anal fistulae and abscesses: diagnostic and therapeutic aspects, excepting Crohn's disease]. J Chir (Paris) 2000; 137: 83-92 [PMID: 10864689]
88. Heitland W. [Fistulas and fissures. Part I: perianal fistulas]. Chirurg 2008; 79: 430-438 [PMID: 18385914 DOI: 10.1007/s00104-008-1487-9]